PCV32 COST-EFFECTIVENESS OF IRBESARTAN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION, TYPE-2 DIABETES AND RENAL DAMAGE IN MEXICO

Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65447-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)65447-2/fulltext
Title : PCV32 COST-EFFECTIVENESS OF IRBESARTAN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION, TYPE-2 DIABETES AND RENAL DAMAGE IN MEXICO
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65447-2&doi=10.1016/S1098-3015(10)65447-2
First page :
Section Title :
Open access? : No
Section Order : 606
Categories :
Tags :
Regions :
ViH Article Tags :